News Medical on MSN1h
Radiation and immunotherapy help preserve bladders in patients with muscle-invasive bladder cancer
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
GlobalData on MSN1d
AstraZeneca’s Imfinzi bladder cancer regimen improves survival in Phase III trial
The treatment regimen reduced the risk of developing distant metastases or death due to bladder cancer by 33%.